Stockreport

Why Xoma, a drug royalty firm, is hunting biotech ‘zombies' [Yahoo! Finance]

LAVA Therapeutics N.V. - Ordinary Shares  (LVTX) 
PDF Four years ago, a record number of biotechnology companies flooded public markets , capitalizing on investor interest in drugmakers amid the COVID-19 pandemic. Since [Read more]